Astal Laboratories

Quarterly
Consolidated
ParticularsMar '25Dec '25Mar '26Jun '26
Revenue23.5152.28134.15101.08
Expenses19.6649.14125.8190.73
EBITDA4.213.5810.2912.39
Operating Profit4.123.469.4311.53
Profit Before Tax3.843.138.3410.35
Net Profit2.742.367.689.42
Financial Ratios
Operating Profit Margin17.98%6.87%7.68%12.27%
Net Profit Margin11.67%4.52%5.73%9.33%
Earning Per Share (Diluted)1.771.741.952.18
Dividends Per Share0.000.000.000.00